Tag Archives: Ilan Sobel

Ilan Sobel on Executing the “Scale-Up” | The CSE Podcast Ep2-S3

We start our second show of the season by revisiting one of the most memorable interviews from last season with Ilan Sobel, CEO of BioHarvest Sciences (CSE:BHSC). On last year’s interview we learned about the driving mission of his company to build “human utility value”. We use that as a jumping-off point as we re-unite after a notable year for the company despite global and economic headwinds.

Ilan provides an update on BioHarvest’s two key product verticals in the  Polyphenol and Cannabis sectors, and how each are taking unique (and in some cases, similar) paths to market. Ilan also reflects on some of the choices the company has made with respect to developing its sales funnel and shares valuable lessons about acting as a “learning” organization and listening to your customers.

Mr. Sobel is Chief Executive officer of  BioHarvest Sciences Inc. (CSE:BHSC)  –  the developer and exclusive owner of the proprietary and patent-protected BioFarming technology. It is the first and only industrial-scale plant cell technology capable of producing the active plant ingredients without the necessity to grow the plant itself. The Company’s technology is non-GMO and has already been validated by VINIA®, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest Sciences Inc. The Company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with VINIA® and other Super Fruit Nutraceutical products. Further, by adapting this technology to the Cannabis plant, and building adequate production capacity, BioHarvest Sciences Inc.’s objective is to become a leading supplier of Cannabis for both medicinal and legal recreational purposes.

Learn more about BioHarvest Sciences at https://bioharvest.com/

Subscribe: Apple Podcasts / Spotify / Stitcher / Google Podcasts / iHeart / RSS

Ilan Sobel on Unlocking Human Utility Value at BioHarvest Sciences | The CSE Podcast Ep1-S2

CSE’s Barrington Miller chats with Ilan Sobel, CEO of BioHarvest Sciences Inc. (CSE:BHSC) to discuss how his company is combining science & technology with the power of nature to develop breakthrough proprietary and patented Biofarming technologies (plant cell growth).

Here’s an overview of what Barrington and Ilan cover in this edition of the podcast:

0:00 – Introducing Ilan Sobel and BioHarvest Sciences
2:45 – What Ilan learned over 18 years at Coca Cola
6:40 – Developing “Biofarming” technology at BioHarvest
10:20 – Incorporating sustainability into their strategies
13:25 – The intersection of biotech and health and wellness
16:15 – Correlating sustainable technologies and cost
19:55 – Advocating for female leadership in biotechnology
25:00 – Building “human utility value”

About BioHarvest Sciences Inc.
BioHarvest Sciences produces and sells a food-based Nutraceutical product called Vinia™ which contains the whole range of piceid resveratrol in natural state. The product is made by growing plant cells from red grapes in bioreactors utilizing BioHarvest’s platform technology which allows the growing of specific cells instead of the whole plant. BioHarvest Sciences is also completing research to adapt its platform technology to the growing of cannabis cells under a cannabis research license in Israel.

Learn more about BioHarvest Sciences Inc. at https://thecse.com/en/listings/life-sciences/bioharvest-sciences-inc

Subscribe: Apple Podcasts / Spotify / Stitcher / Google Podcasts / iHeart / RSS